FACULTY OF MEDICINE, IMPERIAL COLLEGE, LONDON
The ROYAL MARSDEN HOSPITAL
Clinical Senior Lecturer in Colorectal Surgery
1.
THE POST:
Title of Post:
Department:
Main site of activity:
Honorary Contract with:
Associated with:
Responsible to:
Accountable to:
1.1
Clinical Senior Lecturer in Colorectal Surgery (SM00214)
Surgery and Cancer
The Royal Marsden Hospital
The Royal Marsden Hospital
Surgery and Cancer Clinical Programme Group
Professor Paris Tekkis
Professor Ara Darzi
Background to the Post
The post will be full-time and fixed term for 5 years in the first instance. The appointee will have
appropriate office and laboratory facilities at The Royal Marsden Hospital and Chelsea and
Westminster Hospital. Honorary Consultant status with The Royal Marsden Hospital and
Chelsea and Westminster Hospital has been sought. Details of Imperial College London are
attached at Appendix 1.
The post will be supported by the appropriate clinical, non-clinical and support staff relevant for
the development of the clinical and research programme. Appropriate secretarial support will
be provided.
The appointee will be a member of the Department of Colorectal Surgery (led by Professor Ara
Darzi) within the Division of Surgery and the Section of Surgery at the Royal Marsden Hospital
campus.
All members of clinical academic staff are expected to be active and highly respected in clinical
practice, in research, publish papers in leading journals, attend conferences, supervise research
students and obtain funding to support their students and research activities. The appointee will
be expected to have a proven track record in such activities.
This appointment is a central element of the strategic academic development of colorectal
surgery and minimally invasive surgery within the Department of Colorectal Surgery and will
undertake research underpinning the development of emerging technologies, surgical
techniques, clinical and basic scientific research.
Teaching and research are considered to be an integral part of the post. The post will involve
the usual administrative duties associated with a busy academic and research-active
environment and the appointee will be expected to enhance the academic standing of the
Department of Colorectal Surgery. This appointment is a central element of the academic
development of Colorectal Surgery and Minimal Invasive Surgery within the Department of
Surgery and Cancer.
1
The appointee will contribute to the academic aims of the Department by:








Planning and directing relevant basic science research programmes
Planning and leading innovative, interdisciplinary research
Successfully attracting funds for major research initiatives
Extending and interlinking the research strengths already existing within Imperial College
across the Faculties in his/her field of research
Participating in the planning, design and execution of teaching including postgraduate
teaching and research supervision and undergraduate teaching
Participating in postgraduate training and courses for junior and senior doctors in training
Responsibility for patient care and the running of the colorectal clinical service at The Royal
Marsden Hospital
Contributing to the aims and objectives of the Imperial College Institute of Global Health
Innovation
2.
Department of Surgery and Cancer
2.1
An Overview
The Department of Surgery and Cancer is led by Professor Jeremy Nicholson. The Division of
Surgery (Head, Professor George Hanna) comprises sections of Surgery, Anaesthetics, Pain
Medicine and Intensive Care, Division of Computational and Systems Medicine and The Division of
Cancer & Reproductive Medicine (Head – Professor Bob Brown) comprises sections of Oncology
and Obstetrics, Reproductive Biology and Gynaecology.
2.2
The Work of the Department
The Department is highly multi-disciplinary and includes multiple internationally renowned
academic and clinical foci including surgical technology development, discovery biochemistry,
cancer biology and medicine, reproductive medicine, critical care and pain management. Its
overarching mission is to innovate, develop and apply new translational technologies, approaches
and models to enhance medical and surgical diagnostics, clinical decision-making and patient
stratification and to understand the basis of gene-environment diet interactions in relation to
population disease risks and so to better inform health policy decisions and government policy. It
aims to harmonise and develop existing research themes across the Department, and also to
capitalise on world leading molecular phenotyping and metabolic profiling research capabilities to
create a new healthcare paradigm based on a molecules to medicine approach. In particular we
will channel exciting new technology developments into clinical practice with particular emphasis
on development of personalised healthcare and patient stratification strategies across all our
clinical delivery programmes. There are plans to create new world leading centres of excellence in
Surgical Metabonomics, Gut Health and Peri-operative and Trauma care utilising “Top-Down
Systems Biology” principles which will uniquely brand the Department’s research strategy and
aspirations. The Imperial NIHR Clinical Phenome Centre has just been created on the St Mary’s
campus in a prime location immediately adjacent to the Operating Theatres and will provide a
wealth of opportunity for new areas of research.
The Department is responsible for teaching a significant part of the undergraduate and clinical
curriculum to Imperial College medical students across six years of the curriculum.
It is
responsible for two BSc pathways – in Surgery and Anaesthesia and in Obstetrics and
2
Gynaecology. The Department also has an extensive programme of postgraduate teaching,
comprising taught courses, short courses and supervised higher degree students.
2.3 Staffing
Head of Department
Professor Jeremy Nicholson
Director of Education Strategy
and Quality
Professor Alison McGregor
Director of Academic Opportunities
Professor Lesley Regan
Director of Health, Safety and
Compliance
Professor Gerry Thomas
Head of Division of Surgery
Professor George Hanna
Head of Section of Anaesthetics
Pain Medicine and Intensive Care
Professor Masao Takata
Head of Division of Computational &
Systems Medicine
Professor Elaine Holmes
Head of Division of Cancer &
Reproductive Biology
Professor Bob Brown
Head of Section of Obstetrics
Reproductive Biology and Gynaecology
Professor Phil Bennett
Director of Postgraduate Studies
Professor Michael Seckl
Director of Undergraduate Studies
Mr Barry Paraskeva
2.4 Research Activities
The Department has established 4 research themes with the objective of integrating new
technologies into personalised healthcare at the point-of-care to improve patient outcomes:




Molecular Phenotyping Directed Personalised Healthcare
Population, Behaviour and Health Services Research
Molecular Cell Biology and Immunology
Surgical and Robotic Technologies
These themes are cross-departmental, providing a research framework for research groups within
the Department of Surgery and Cancer that have not been previously connected to work together
for common healthcare goals. The themes also have cross-Faculty connections, e.g. with
Bioinformatics, Systems Biology and Bioengineering groups, and are closely aligned with the
AHSC research strategy and CPG needs.
3
2.5 Teaching Activities
The Department is responsible for teaching a significant part of the undergraduate and clinical
curriculum to Imperial College medical students across six years of the curriculum.
It is
responsible for two BSc pathways – in Surgery and Anaesthesia and in Obstetrics and
Gynaecology. The Department also has an extensive programme of postgraduate teaching,
comprising taught courses, short courses and supervised higher degree students.
The Head of the Division is Professor George Hanna and there are Heads of the Section at
Hammersmith (HPB) - Professor Nagy Habib and at Charing Cross (Musculoskeletal) – Professor
Justin Cobb. The Division has major strengths in new technology, imaging and computing,
ergonomics, patient safety and clinical effectiveness. The research carried out is driven by
interdisciplinary working and the themes of best surgical practice, clinical safety and education by
applying science and technology to issues directly affecting patient care. Translational research is
integral to the Division’s success, developed by cross-faculty collaborations with the Department of
Computing, Department of Mechanical Engineering, the Business School as well as with Schools,
Institutes and Departments within the Faculty of Medicine.
The Division has built strong relationships with industry, government, healthcare providers, and
educational institutions for the translation of its research into practical applications. In conjunction
with Computing, the Division has concentrated its research activities around new technology –
robotics, image-guided surgery, biological sensors, ergonomics and human performance to create
The Hamlyn Centre. There are strong links with the Royal Marsden Hospital NHS Foundation
Trust following the endowment of the Paul Hamlyn Chair of Surgery in 2005 held by Professor Ara
Darzi, and the creation of a single Academic Department of Surgical Oncology with the Institute of
Cancer Research. Professor Paris Tekkis holds a joint appointment and is based at the Royal
Marsden and Chelsea and Westminster Hospital NHS Foundation Trust. It also forms part of an
important cross-College consortium exploring musculoskeletal disease mechanisms in order to
understand mechanical, motor control, muscular, hereditary, lifestyle and other parameters that
lead to the development of chronic disease and to use this understanding to delay onset and
progression.
The Division houses one of two NIHR Centres for Patient Safety and Service Quality, led by
Professor Ara Darzi and Professor Charles Vincent. It comprises a highly specialised set of
academic and clinical research groups, which collectively aim to trial new approaches and
technologies to reduce human error and improve patient care. Furthermore, Imperial College has a
strong reputation in the field of educational research. Its pioneering work in surgical education was
first recognized by the Queen’s Anniversary Prize for Higher and Further Education in 2001. The
Surgical Skills and Education Research agenda drives competency assessment and development
of training to support dissemination of new technologies.
The Division also hosts the Surgery and Technology BRC theme led by Professor Ara Darzi as the
theme leader, which was recently renewed for five years. The Surgery and Technology theme
combines the research excellence in science and technology at Imperial College London and the
pioneering surgery and translation. It embraces the innovation pathway in surgical practice from
invention to adoption and diffusion via:
 Translational research in areas of novel and smart surgical instruments and devices including
Robotic Surgery, Surgical Imaging and Sensing, and original surgical technology platforms
such as Single Incision Laparoscopy (SILS) and Natural Orifice Translumenal Endoscopic
Surgery (NOTES).
4


Effective and safe introduction of new innovations into clinical practice. This is achieved
through the design and validation of novel training tools such as surgical simulators and
building safety resilience in complex environment and health systems.
Addressing the main challenges in technology adoption and diffusion through evidence base
synthesis, policy translation and entrepreneurial commercialisation of technology.
The research theme is led by the Division of Surgery and its constituent research centres, in the
form of NIHR Centre for Patient Safety and Service Quality (CPSSQ), the Centre for Health Policy,
Institute of Global Health Innovation (IGHI), and The Hamlyn Centre, in which both the Faculty of
Medicine and the Faculty of Engineering are stakeholders.
There is a strong programme for both undergraduate and postgraduate teaching including
participation in the Surgery and Anaesthetics pathway of the BSc programme. It has a portfolio of
postgraduate taught courses including the Masters in Surgical Education, MSc programmes in
Surgical Sciences, Surgery Technology, Safety and Quality and Surgical Technology. The
inclusion of Anatomy and Communications enhances the opportunities available for development
of new and innovative methods of education and training at both undergraduate and postgraduate
levels.
The Division of Surgery Section at Hammersmith Hospital comprises HPB surgery (Professor
Nagy Habib, Professor of Hepatobiliary Surgery, Professor Andrea Frilling, Mr Long Jiao, Reader
in Surgery, Mr Duncan Spalding, Clinical Senior Lecturer, Dr Paul Mintz, Non Clinical Senior
Lecturer, Joanna Nicholls, Research Manager, Mrs Benita White, Academic Secretary), Professor
Paul Abel, Academic Urology, and Professor Nigel Standfield, Vascular Surgery. HPB and
Endocrine research is focused on Team B6 with early detection and monitoring of cancer therapy
and Team C3 with stem cell development.
3.
The Royal Marsden Hospital NHS Foundation Trust
3.1 An Overview
The Royal Marsden Hospital is recognised world-wide for the quality of its cancer services. The
Trust’s strategic aim is to achieve excellence in cancer treatment and diagnosis, through
partnership and collaboration. The Royal Marsden, with its associated Institute of Cancer
Research, constitutes a centre of excellence for research and development, education,
treatment and care in cancer. It is acknowledged to be one of the largest comprehensive
Cancer Centres in the world.
The prime purpose of the Trust is the provision of state of the art cancer services as well as
enabling research into the development of improved methods of prevention, diagnosis and
treatment of cancer. Its other main purpose is teaching and the dissemination of knowledge
both nationally and internationally. In 1991, it became the first NHS hospital to be awarded the
Queen’s Award for Technology for its work on drug development. The hospital gained National
Charter Mark Awards in 1995, 1998 and again in 2001 for the excellence of its service and in
1996 achieved the international quality standard ISO 9001 for radiotherapy and for
chemotherapy in 2003. It was recognised as one of six centres of excellence in the
Government’s NHS Plan and has achieved four national Charter Marks for all services, the
most recent awarded in 2005. The Royal Marsden has consistently been awarded three stars
and more recently double Excellent rating in the last two years in the NHS performance
indicators, rating it among the best in the country in terms of clinical quality and patient care.
5
The Royal Marsden and The Institute of Cancer Research form the United Kingdom’s only
designated Biomedical Research Centre for Cancer – awarded in December 2006 by The
National Institute for Health Research (NIHR). As a leading Cancer Centre, the Trust has close
working relationships with many Cancer Units and other Cancer Centres. Predominantly, the
Trust’s workload is from within the South West and West London Cancer Networks but the
Trust is unique in having a high out-of-area referral rate for rare cancers, recurrent disease and
treatment-related problems.
The Royal Marsden NHS Foundation Trust comprises two units (169 beds at Chelsea, and 184
beds at Sutton). Over 30,000 patients attend the Royal Marsden each year. The Trust employs
2300 staff, including 244 medical staff. As a specialist cancer centre, the Trust serves local
populations within the London Boroughs of Merton, Sutton, Wandsworth, Kensington &
Chelsea and Westminster, as well as receiving referrals both nationally and internationally.
Organisation
The Trust Board comprises an independent chair, Ian Molson, executive directors, (Chief
Executive, Chief Nurse, Director of Finance, Medical Director), and five non-executive directors
from outside the NHS.
At The Royal Marsden NHS Foundation Trust the hospital management structure is organised
into two Divisions: Cancer and Clinical Services. Each Division is managed by a Divisional
Director and supported by a Divisional Medical Director. The consultants heading up each
Clinical Unit or specialty is a member of the Medical Advisory Committee. This is chaired by the
Medical Director, Professor Martin Gore, who together with the other directors (i.e. Chief Nurse,
Finance, IT, Strategy & Service Development, HR, Private Practice and Estates) and the
Divisional Directors form the Management Executive. The Management Executive is chaired by
the Chief Executive, Miss Cally Palmer.
The Divisions comprise the following services:
Paediatric Unit, Head & Neck Unit, Haemato-Oncology Unit, Neuro-oncology Unit, Sarcoma
Unit, Thyroid Unit, Skin and Melanoma Unit and Clinical Pharmacology Unit, Anaesthetics and
Intensive Care / High Dependency, Pain service, Cancer Genetics, Palliative Care, Pathology,
Imaging, Therapeutic Radiotherapy, Theatres and Day Surgery, Nuclear Medicine, Physics,
Pharmacy, Medical Records, Patient Transport, Outpatients Department, Breast Unit, GastroIntestinal Unit, Lung Unit, Urological Unit, Gynaecology Unit.
Cancer Services Division
This comprises of the following units:
Paediatric Unit, Head & Neck Unit, Haemato-Oncology Unit, Neuro-oncology Unit, Sarcoma
Unit, Thyroid Unit, Skin and Melanoma Unit and Clinical Pharmacology Unit, Breast Unit,
Gastro-Intestinal Unit, Lung Unit, Urological Unit, Gynaecology Unit. The Divisional Director is
Mrs Liz Bishop and the Divisional Medical Director is Professor Andy Pearson. The Consultant
heads of each clinical unit or specialty formally meet as the Divisional Management Team on a
bi-monthly basis.
Clinical Services Division
This comprises of the following units:
Anaesthetics and Intensive Care / High Dependency, Pain service, Cancer Genetics,
Palliative Care, Pathology, Imaging, Therapeutic Radiotherapy, Theatres and Day Surgery,
Nuclear Medicine, Physics, Pharmacy, Medical Records, Patient Transport, Outpatients
6
Department. The Divisional Director for Clinical Services is Mr Ian Haig, and Divisional
Medical Director is Dr Tim Wigmore.
In addition the Divisions are supported by the following Directorates:
Nursing, Rehabilitation and Quality Assurance Directorate comprising:
Rehabilitation Department (Physiotherapy, Occupational Therapy, Dietetics, Speech Therapy,
Lymphoedema Service, Therapeutic Massage, Pastoral Care, Clinical Psychology,
Complementary Therapies, Senior CNS Lymphoedema, Patient Information, Volunteer
Services, Community Liaison, Social Services), Quality Assurance Department, Research,
Practice and Professional Development Department, Finance Directorate, Human Resources
Directorate, Computing and Information Directorate, Facilities Directorate.
4. The Work of The Royal Marsden Hospital Gastrointestinal (GI) Unit
4.1
Workload and Facilities
The GI Unit
The GI Unit at The Royal Marsden is a multidisciplinary unit which focuses on the
management and research of patients with upper GI and colorectal cancers:
• Oesophago-gastric
• Pancreatic
• Liver
• Colorectal
• Anal
A comprehensive oncological GI service is offered which provides patients with a complete
range of treatment options on site. Each year, around 750 patients receive treatment under the
care of the GI Unit. A total of 274 new cancer and 225 follow-up patients were discussed at the
multidisciplinary cancer meeting in 2013 with 110 colorectal resections performed within the
last 12 months.
An expanding service provides a dedicated clinic at the Chelsea site of the hospital, which is
available to see patients referred with symptoms of colorectal cancer. The Unit is also in a
position to provide second opinions to patients at any stage of their disease.
4.2
Staffing
Present Staffing in the GI Unit
Consultants – Surgery (Colorectal)
Prof Lord Ara Darzi
Prof Paris Tekkis
Mr Shahnawaz Rasheed (locum consultant)
Consultants – Surgery (Upper GI and HPB)
Mr William Allum
Mr Jeremy Thompson
Mr Satvinder Mudan
Mr Aamir Khan
7
Trainee Surgical Staff
SpR – 1 colorectal, 2 upper GI/HPB
International post-CCT fellow – 1 colorectal
SHO – 1 colorectal, 1 upper GI/HPB
Consultants – Medical Oncology
Prof David Cunningham (Head of GI Unit)
Dr Ian Chau
Dr Sheela Rao
Dr Naureen Starling (locum consultant)
Dr Sarah Nagn (locum consultant)
Consultants – Clinical Oncology
Dr Diana Tait
Dr Nick van As
Dr Maria Hawkins
Consultants – Gastroenterology
Dr Jervoise Andreyev
Dr Julian Teare
Dr Martin Benson
CNS
Ramani Sitamvaram
Toni Cole
Adi Coleman
Michelle McTaggart
Hannah Perry
Alison Massey
Maria Crisford
Katy Hardy
MDT Navigators
Karen Bottomley-wise (colorectal)
Jacky Pach (upper GI)
Secretarial and information support are provided by the multi-disciplinary unit system within
which the appointee will work.
4.3
Research Activities of the Royal Marsden Hospital
Research is a very high priority for The Royal Marsden and there are many active research
programmes within the GI Unit which are open to collaboration. There are already
programmes of research in surgery, radiotherapy, chemotherapy and genetics. Involvement in
some of these established programmes and development of new areas of research, in
collaboration with other disciplines, departments in the Trust, the Department of Surgery and
Cancer at Imperial College and the Institute of Cancer Research, is actively encouraged.
Clinical trials have been highlighted as an indicator for the quality of clinical services and
currently, a number of these are being undertaken in the Gastrointestinal Unit of RMH. This
post will offer support in the management of these ongoing clinical trials which are being
8
supported by RMH, NCRI and various other funding bodies. There is an established highly
successful track record of undertaking high level, productive research at Imperial College and
the NIHR Specialist Biomedical Research Centre for Cancer and of generating significant
funds to enable further development and sustainability. The postholder will aim to raise funds
for future clinical research, clinical trials and basic science research as a PI or co-PI supported
by Professor David Cunningham, Professor Ara Darzi and Professor Paris Tekkis.
4.4
Teaching Activities of the Royal Marsden Hospital
The Trust is actively involved in surgical training. There is increasing competition from trainees
to come to the unit for a period of specialist training. All consultants are expected to be involved
in the training of Specialist Registrars, Specialist Trainees, Core Trainees and visiting trainees.
In addition, collaboration in training programmes for radiographers, nurses, medical physicists
and allied paramedical staff is expected.
4.5
Relationship with other SIDs, Faculties and CPGs
This post will link directly with the Department of Surgery and Cancer, Imperial College
London. Cross-faculty links will be expected to be made at the:

NIHR-BRC at RMH and Imperial College for cancer research and management.

Institute for Global Health Innovation to promote the management of cancer globally.

Imperial College Clinical Trial Unit to support clinical trials in recurrent and advanced
colorectal cancer.
The work in the themes outlined will interact with the following centres across the faculty:
(i)
Imperial College Clinical Trial Unit: A group/ unit with interest in clinical trials will be
established in the Division of Surgery. This group will interact strongly with the IC trial unit
and follow its governance structure. (Professors Atkins, Ashley and Poulter)
(ii) NIHR Specialist Biomedical Research Centre for Cancer at RMH. To be further developed
between the potholder in conjunction with Professor David Cunningham.
(iii) Institute for Global Health Innovation: To pursue a collaborative partnership between the
postholder and the IGHI to promote global health from an International Development,
Disaster Response and Cancer perspective (Professor Ara Darzi)
5.
The Post - Key Result Areas, Main Duties and Responsibilities
The Clinical Senior Lecturer and Honorary Consultant post has been devised to support the
team who currently provide diagnostic and oncological colorectal services to patients within and
outside South West London.
The postholder will work under Professor Ara Darzi and alongside Professor Paris Tekkis and
will be expected to take part in the diagnostic service for colorectal cancer, ensuring timely
access to review and investigations for all those patients referred to The Royal Marsden
Hospital. He/she will be trained in laparoscopic surgery and will be required to support the Head
of the GI Unit and Divisional Clinical Director in policy and strategic development as a member
of the Cancer Services Division. The postholder will be responsible for his/her own continuing
9
professional development and take part in continuing medical education activities, in line with
the requirements of the appropriate Royal College guidelines to maintain and develop standards
of performance.
The appointee will contribute to the improvement and sustainability of 18 week and cancer
access targets. In addition, the postholder will aim to reduce length of hospital stay through
innovative delivery of care including minimally invasive surgery and further implementation of
the Enhanced Recovery Programme. In addition, the postholder will aim to reduce outpatient
follow up appointments through taking part in an improving outcomes initiative by using risk
stratified follow-up care for cancer patients. The appointee will play an integral role in the wider
GI Unit, provide input to colorectal MDT meetings, help to provide support for GI emergencies,
manage a diagnostic and therapeutic endoscopic service, run colorectal surgical outpatient
clinics, manage an elective surgical service for primary colorectal cancer patients and support
the management of locally advanced and recurrent colorectal cancer with guidance and support
from Professor Ara Darzi and Professor Paris Tekkis in conjunction with the wider multidisciplinary team.
This appointment is a central element of the academic development of colorectal surgery and
minimally invasive surgery within the Department of Colorectal Surgery at RMH. This will further
contribute to building on the reputation of the Royal Marsden in collaboration with Imperial
College as world leading centres of excellence.
The postholder will be expected to take part in an on-call rota with her/his Consultant colleagues
and in the cover arrangements and junior supervision during colleagues’ annual and study
leave. Currently the on-call commitment is 1:8 weekdays and 1:10 on call. Access to a
computer, telephone and Electronic Patient Record and secretarial support will be provided.
5.1
Provide High Quality Care to Patients in the Royal Marsden Hospital



To develop and maintain the competencies required to carry out the duties required of the
post.
To ensure prompt attendance at agreed direct clinical care Programmed Activities.
To ensure patients are involved in decisions about their care and to respond to their
views.
The care of in-patients will be undertaken in conjunction with fellow Consultants in the associated
hospitals.
5.2
Research
The post-holder will work under the guidance of Professor David Cunningham, Professor Ara
Darzi and Professor Paris Tekkis in continuation of current research activities. The research
strategy aims to engage in cross-platform deliverables which include translational research,
evidence based medicine, surgical quality and epidemiology, surgical technology and
teaching.
The following Themes will be supported:
i. Centre for Systems Oncology and Cancer Innovation: the appointee’s work pattern
at RMH and Imperial will be well-placed to work closely with the centre in advanced
colorectal cancer field.
10
ii. Imperial College Cancer Research UK centre: the appointee will contribute to medical
technology theme in the centre.
iii. Surgical Therapeutic Clinical Trial Theme in the Division of Surgery unit with
reference to advanced and recurrent cancer.
iv. MRC-NIHR National Phenome centre: the appointed clinician will provide the route to
impact for the new centre. Much collaboration is needed between scientist and clinicians
in order to personalise metabolic profiling and introduce it in clinical practice.
(Professors Nicholson and Holmes).
v. Surgical technology: a major theme at the Division of Surgery with links to NIHR-BRC
and NIHR Diagnostic Evidence Cooperatives.
vi.Centre for Health Policy: with cancer being a major cause of death globally and
interest in major humanitarian international disaster management.
The post holder will work in the following research themes of the Department of Surgery and
Cancer / RMH:
(i)
(ii)
Clinical trials: The postholder will support the management of clinical trials relating to lower
GI diseases including cancer, and inflammatory disorders. There is opportunity to utilise the
existing excellent infrastructure in technology research, phenotyping, cancer and metabolic
medicine both at Imperial College and at the NIHR Specialist Biomedical Research Centre
for Cancer at RMH.
Clinical research: The postholder will support the ongoing clinical research of Professor Ara
Darzi and Professor Paris Tekkis including assessment of outcomes in primary, locally
advanced and recurrent colorectal cancer
(iii)
Basic science research: Further work will be undertaken to investigate the role of
angiogenic and hypoxic factors in the development and progression of CRC. In addition,
further investigation will be conducted into the role of angiogenic factors in prognosis and
potential use of novel anti-angiogenic agents in the treatment of CRC.
(iv)
Transitional cancer research: The interaction between surgeons and medical oncologists
and cancer scientists is essential for the two divisions of the department (surgery and
cancer). There is a great opportunity to develop minimally invasive interventions for drug
delivery that combines both technological interventions, cancer scientific discovery into a
clinical context.
Surgical Education: the post holder will fill the emerging needs in postgraduate training of
registrars and the new masters in surgery. The post-holder will have a unique opportunity to
develop innovative methods to deliver postgraduate educational initiatives.
(v)
(vi)
Disaster Response Medicine: to further the understanding of medicine applied to the postdisaster environment. Planned collaboration with national and international bodies to
improve on the knowledge and delivery of medical care to patients following international
disasters.
(vii) Global cancer services: to explore the promotion of the RMH globally to improve on the
delivery of cancer services in low and middle income countries (LMICs). This may include
advocacy, research, education and training in addition to assistance with the determination
and delivery of national strategies, advice on infra-structure development and knowledge
transfer support.
11
The research model marries clinical excellence, innovation and education within an
environment that nurtures multidisciplinary collaboration, openness, mutual respect and strong
ethical standards. The following research themes are currently being undertaken with the
objective of integrating innovation into personalised healthcare at the point-of-care to improve
patient outcomes:
i.
ii.
iii.
iv.
Locally advanced rectal cancer: Continuing clinical research with the ongoing
investigation of a prospectively collected database containing all patients with locally
advanced abdominal and pelvic malignant disease with outcomes for patients. Factors
investigated include radiological assessment, surgical techniques, pathological
variables, response to neo-adjuvant and adjuvant therapies.
Recurrent colorectal cancer: Ongoing clinical research trials investigating current
practice in recurrent colorectal cancer including the assessment of factors which
influence outcomes.
Early and minimal invasive colorectal cancer: Ongoing investigation into the
expanding role of laparoscopic / TEM / endoscopic surgery in the management of
colorectal cancer.
Clinical trials: Numerous clinical trials are being undertaken by the Gastrointestinal
Unit including the use of both chemotherapy and radiotherapy in the neo-adjuvant,
adjuvant and palliative setting.
The postholder will be expected, in line with the IC Faculty of Medicine’s minimum academic
performance criteria to:






be successful in the acquisition of grants
run a research area with scientists, clinicians, technicians and students at the highest
scientifically rigorous level.
collaborate with other allied scientists within Imperial College London including the Institute
for Global Health Innovation and elsewhere in London and abroad.
publish in high quality journals
supervise postgraduate research students
co-ordinate outcome studies in his/her particular area of interest take part in audit.
And will be expected to be involved in:



provision of expert advice internally and externally
contribution to the development of the Division/Department’s research strategy as it forms
part of the research strategy of the Faculty of Medicine and work with the BRC theme
leader in fulfilling the deliverables of the BRC award.
Participation in national, and where appropriate, international programme formulation,
developing research strategies and reviews as appropriate.
These themes are cross-departmental, providing a research framework for research groups within
the Department of Surgery and Cancer that have not been previously connected to work together
for common healthcare goals. The themes also have cross-Faculty connections.
This is an essential post that contributes to the NHS surgical capacity plan to meet the 18 week
performance demand in general surgery and is key in meeting cancer access targets for the lower
GI tumour group. The surgical management of colorectal cancer occurs at the Chelsea site of the
12
Royal Marsden Hospital. This post is one of three lower GI consultant positions, including
Professor Ara Darzi and Professor Paris Tekkis.
Overview of post
RMH & IC
Department
of Colorectal
surgery /
Proposed
CSL
Clinical
activity
Surgery early
and
advanced
cancer
Imaging
Endoscopy
Radiotherapy
and
chemotherapy
Research
General
surgery
on-call
Current Clinical Staff
Prof David Cunningham - Head of GI unit
Prof Ara Darzi - Head of Department
Prof Paris Tekkis - Academic Surgery
Dr Gina Brown - Radiology
Dr Sue Chua - Nuclear Medicine
Dr Daniel Levine – Nuclear Medicine
Dr Diana Tait - Clinical Oncology
Dr Ian Chau - Medical Oncology
Dr Nick van As - Clinical Oncology
Mr Shahnawaz Rasheed - (Locum) Surgery
Dr Naureen Starling - (Locum) Medical oncology
Prof Gordon Stamp - Clinical Pathology
Clinical
trials
Biomedical
research
RMH
Clinical
Trails
Unit
South
Kensington
campus
St Mary’s
for
clinical trials
NIHR
Biomedical
Research
Centre for
Cancer
Global
Health
Education
& training
Epidemiology
and
surgical
outcomes
Surgical
technology
and
innovation
IC Institute
for
Global
Health
Innovation
Dr Andrew Weatherspoon - Clinical
pathology
5.3
Teaching and Training
 Teach and examine courses to all levels – undergraduate, masters and higher research
degrees, through lectures, seminars, course work, tutorials and clinical training and
personal supervision
 Contribute to the Undergraduate and Graduate Entry programme
 Plan and review own approach to teaching
13
 Develop and review approaches to education which advance techniques and standards
locally and contribute to local policy developments
 Act as a coach and role model through excellent practice and mentoring colleagues
 Contribute generally to the development of teaching and teaching methods and
assessments
 Supervise and examine MD Res/ PhD students both internally and externally
 Provide pastoral support for students
 Contribute to the enhancement of quality in teaching within the field
 Contribute to curriculum development
 Train junior medical and nursing staff in the clinical setting
External activities



5.4
Act as an external examiner for postgraduate students
Work, as appropriate, with national bodies on curriculum development and quality
assurance
Represent the Division, Faculty and College as appropriate
Staff Management
 To take responsibility for the appointment, management and development of College staff,
in line with College policy and procedure.
 To undertake the Performance Review and Development Plan annually for all College staff
managed.
 To work with colleagues to ensure junior doctors’ hours are compliant in line with EWTD
and New Deal.
 To ensure that adequate systems and procedures are in place to control and monitor leave
for junior medical staff and to ensure that there is appropriate cover within the clinical
areas, including on-call commitments.
 To participate in the recruitment of junior medical staff as delegated by the CPG
Director/Clinical Director.
 To participate in team objective setting as part of the annual job planning cycle.
 To be responsible for the annual appraisal of academic/research staff for whom the post
holder is responsible as delegated by the Head of Department, all doctors in training, Trust
doctors and non-consultant grades as delegated by the CPG Director/Clinical
Director/General Manager.
5.5
Clinical Performance Management
 To work with medical, nursing and managerial colleagues to ensure high performance in
the following areas:

Clinical efficiency e.g. LOS reductions, reducing cancelled operations and DNA
rates.

Quality of outcomes e.g. infection control targets, reducing re-admission rates

Financial management e.g. identification, implementation and achievement of cost
improvement programmes and participating in efforts to ensure services are
provided cost effectively e.g. managing locum agency spend, monitoring and
managing the drug budget to target, ensuring accuracy of clinical data for the team

Operational efficiency e.g. day-case rates, waiting list activity and demand
management.
14
5.6
Clinical Governance
 To review clinical outcomes in designated areas using external benchmarking data where
appropriate, to identify and advise variances to the Head of Department.
 To participate in clinical audit, incident reporting and analysis and to ensure resulting
actions are implemented.
 To work closely with the Directorate, Patient and Public Involvement panels in relation to
clinical and service developments as delegated by the Head of Department.
 To participate in ensuring NICE requirements are reviewed and implemented and
monitored in the speciality areas.
 To ensure clinical guidelines and protocols are adhered to by junior medical staff and
updated on a regular basis.
 To keep fully informed about best practice in the speciality areas and ensure implications
for practice changes are discussed with the Head of Department.
 To role model good practice for infection control to all members of the multidisciplinary
team.
 The postholder will be required to maintain a programme of continuous professional
development and revalidation of registration as required by external agencies an also to
comply with the NHS Trusts’ clinical governance procedures. The NHS Trusts have clinical
governance structures to deal with Clinical Risk Management, Clinical Effectiveness and
Clinical Service Development.
 The postholder will be required to participate in regular clinical audit meetings, both
departmental and across the NHS Trust, including mortality meetings and participation in
Grand Rounds.
5.7
Strategy and Business Planning
 To participate in the business planning and objective setting process for the Colorectal
Department, RMH, Clinical Programme Group and NHS Trust where appropriate.
 To make a significant contribution to building and establishing links between the
appropriate research sections of the Colorectal Department and colleagues in other parts of
the Faculty and wider College.
 To play an active part in the strategic planning of financial, staff and research resources.
 To represent the Colorectal Department, RMH, Faculty and College at external meetings,
as appropriate.
 To represent the NHS Trust at appropriate clinical networks/other external clinical
meetings, as delegated by the Head of Department/CPG Director/Clinical Director.
5.8
Leadership and Team Working
 To demonstrate excellent leadership skills with regard to individual performance, academic
teams, the Colorectal Department, Faculty, College, clinical teams, the NHS Trust and
when participating in national/international initiatives.
 To work collaboratively with all members of the multi-disciplinary team and Imperial College
as required.
 To chair regular meetings for the specialties.
 To resolve conflict and difficult situations through negotiation and discussion, involving
appropriate parties.
15
 To adhere to College/NHS Trust guidelines on leave including reporting absence.
5.9
Management and Administrative duties
 To play an active part in the management of financial, staff and research resources, in line
with College policy and procedure.
 Administrative responsibilities in the postgraduate section of RMH
 Administrative responsibilities in the lower GI cancer unit and contribution to the colorectal
MDT
 RMH surgical Lead for the National Emergency Laparotomy Audit (NELA) commissioned
and funded by the Healthcare Quality Improvement Partnership (HQIP)
 Administrative responsibilities associated with general surgical workload
 General contribution to the running of the surgical directorate; operational and financial
performance, efficiency and productivity measures and patient experience
 To undertake any other appropriate administrative duties, as required.
6.
Appraisal and Performance Review Systems
Clinical staff
A system of joint Academic/NHS Appraisal is in place for all Consultant Clinical Academic staff of
Imperial College London with honorary contracts at The Royal Marsden Hospital. This is
conducted on an annual basis in conjunction with a review of the postholder’s job plan.
The job plan will be a prospective agreement that sets out the duties, responsibilities and
objectives for the coming year. It should cover all aspects of a Consultant’s professional practice
including clinical work, teaching, research, education and managerial responsibilities.
It should provide a clear schedule of commitments, both internal and external. In addition, it should
include personal objectives, including details of their link to wider service objectives, and details of
the support required by the Consultant to fulfil the job plan and objectives.
7.
Job Plan
A formal job plan will be agreed annually between the postholder, the Head of the Colorectal
Department, RMH and CPG Director, on behalf of the Medical Director and with the Head of the
Division of Surgery, FoM. The example given below is not designed to be exhaustive.
The postholder, the Head of Colorectal Department and the CPG Director/ Chief of Service and
Head of the Division of Surgery, FoM will review the job plan annually in line with the provisions of
the Terms and Conditions of employment. Either may propose amendment of the job plan.
Academic Activities
5 PA’s per week (including
administrative responsibilities)
Clinical Activities
5 PA’s per week (including clinical activity, clinically related
activity, predictable and unpredictable emergency work)
16
research,
teaching
and
Monday
Tuesday
Wednesday
Thursday
Friday
am
08.00-09.00
LGI MDT (1:1)
09.00-13.30
Admin /
Research
(1:1)
08.00-17.00
Research
(1:1)
08.00-13.00
Research /
Teaching
(1:1)
08.00-17.00 *
Theatre (1:2)
Or
08.00-17.00
Research
(1:2)
08.00-13.00
Theatre *
(1:2)
08.00-13.00
Research
(1:2)
pm
14.00-17.00
Endoscopy
(1:1)
14.00-17.00
OPD (1:1)
08.00-17.00 *
Theatre (1:2)
Or
08.00-17.00
Research
(1:2)
14.00-17.00
OPD (1:1)
* The post-holder will be offered the opportunity to have additional operating lists to cover Prof
Darzi and Prof Tekkis when away on academic or annual leave.
Regular meetings: Colorectal Department to include monthly committee meetings, monthly
operational meetings, monthly Consultant meetings, rolling programme of directorate meetings, ad
hoc meetings.
On call: 1:8 weekday and 1:11 weekend rota.
8.
Administrative/secretarial support:
The post holder will be supported by appropriate administrative and secretarial support staff at The
Royal Marsden Hospital.
9.
Office Facilities
The post holder will have office and research facilities with computer access at The Royal Marsden
Hospital and Chelsea and Westminster Hospital.
10.
Other Responsibilities


To observe and comply with all College policies and regulations, including the key policies
and procedures on Confidentiality, Conflict of Interest, Data Protection, Equal
Opportunities, Financial Regulations, Health and Safety, Imperial Expectations (for new
leaders, managers and supervisors), Information Technology, Private Engagements and
Register of Interests, and Smoking.
To undertake specific safety responsibilities relevant to individual roles, as set out on the
College Website Health and Safety Structure and Responsibilities page
(http://www3.imperial.ac.uk/safety/policies/organisationandarrangements).
17
Job descriptions cannot be exhaustive and so the post holder may be required to undertake
other duties, which are broadly in line with the above key responsibilities.
Imperial College is committed to equality of opportunity and to eliminating discrimination.
All employees are expected to adhere to the principles set out in all equal opportunities
policies and procedures, and all other relevant guidance/practice frameworks.
18
11.
Person Specification
Attributes/skills
Essential
Desirable
Qualifications
GMC registered Medical
Practitioner
GMC specialist
registration or within 6
months of being admitted
to the GMC’s specialist
register
Higher qualifications
Appropriate Royal College
Membership
Further Higher Degree
(PhD or equivalent)
Completion of
a Laparoscopic
Colorectal
Fellowship
Measurement
Application form
Surgical
Fellowship in
speciality
Documented
experience in
exenterative,
multi-visceral
surgery for rectal
cancer
JAG accreditation for
colonoscopy
Research Experience
Have a recognised
reputation in their field of
research
Track record of publishing
in national peer-reviewed
journals
Have a sustained track
record in attracting high
levels of research funding
Have extensive
experience in leading the
design of research
programmes Have
experience and capability
to act as a role model in
areas of research,
teaching and
management as
appropriate
Knowledge/Skills
Clinical training and
19
Application/interview
Clinical expertise in
Specialty/sub
specialty
experience in
General Surgery
equivalent to that
required for a UK CCT
Statement regarding
appropriate training and
experience including that
relating to a special
interest
Leadership/
Management skills
Able to take responsibility,
show leadership, make
decisions, exert
appropriate authority
Application/interview
Have proven skills in
leading, motivating,
developing and managing
the performance of
colleagues
Show evidence of
contribution to the
development and
performance of colleagues
through training, coaching
and mentoring
Knowledge of
finance/budgets
Teaching /Training
Audit
Academic
achievements
including
research/publications
Interpersonal Skills
Management of staff
Experience of teaching
and training
undergraduates
/postgraduates and junior
medical staff
Understanding of
principles of clinical audit
Evidence of achievement
appropriate to
appointment at consultant
level
Excellent written and
spoken communication
skills, ability to build
rapport, work with others.
Persuade, negotiate
20
Application/interview
Application/interview
Application/interview
Interview
Empathy, understanding,
listening skills, patience,
social skills appropriate to
different types of patient.
Able to change and adapt,
respond to changing
circumstances and to cope
with setbacks or pressure
Able to work as part of a
team
As this post is exempt from the Rehabilitation of Offenders Act 1974, a satisfactory enhanced
Disclosure and Barring Service check will be required for the successful candidate. Further
information
about
the
DBS
disclosure
process
can
be
found
at
http://www.homeoffice.gov.uk/agencies-public-bodies/dbs/ or by telephoning 0870 90 90 811. You
may also wish to view the College’s policy statements on the Recruitment and Employment of ExOffenders and the Secure Storage, Use, Retention & Disposal of Disclosures and Disclosure
Information.
Imperial Expectations
These are the 7 principles that Imperial leaders, managers and supervisors are expected to follow:
1) Champion a positive approach to change and opportunity
2) Communicate regularly and effectively within, and across, teams
3) Consider the thoughts and expectations of others
4) Deliver positive outcomes
5) Encourage inclusive participation and eliminate discrimination
6) Support and develop staff to optimise talent
7) Work in a planned and managed way
21
APPLICATION
Our
preferred
method
of
application
is
online
via
our
website
http://www3.imperial.ac.uk/employment. Please complete and upload an application form as
directed.
A full curriculum vitae should be included with your application including the following information:








Applicant’s full name, private address and private telephone number
A confidential fax number and e-mail address, where possible
Degrees (including University and dates)
Past and present posts
List of publications
Brief description of future research plans
Names, addresses and, email, fax numbers, of three referees.
Information on research grants and contracts which have been obtained, student
supervision, etc.
Job Reference: SM002-14
Closing Date: 27 April 2014
22
APPENDIX 1
IMPERIAL COLLEGE LONDON
Imperial College London consistently achieves one of the highest rankings nationally and
internationally, as listed in the Times Higher QS World University Rankings 2012-2013.
The President and Rector, Sir Keith O’Nions FRS, is the College’s academic head and chief
executive officer. The Chairman of the Court and Council is Baroness Eliza Manningham-Buller.
The Mission
Imperial College embodies and delivers world class scholarship, education and research in
science, engineering and medicine, with particular regard to their application in industry, commerce
and healthcare. We foster interdisciplinary working within the College, and collaborate widely
externally.
Strategic Intent
The College’s vision and intent is to:
Continue to be a world-leading institution for scientific research and education,
To harness the quality, breadth and depth of our research capabilities to address the difficult
challenges of today and the future,
To develop the next generation of researchers, scientists and academics,
To provide an education for students from around the world that equips them with the knowledge
and skills they require to pursue their ambitions,
To make a demonstrable economic and social impact through the translation of our work into
practice worldwide,
To engage with the world and communicate the importance and benefits of science to society.
Formation and History
Imperial College was established in 1907 in London’s scientific and cultural heartland in South
Kensington, as a merger of the Royal College of Science, the City and Guilds College and the
Royal School of Mines. St Mary’s Hospital Medical School and the National Heart and Lung
Institute merged with the College in 1988 and 1995 respectively.
Charing Cross and Westminster Medical School and the Royal Postgraduate Medical School
merged with the College on 1 August 1997 to form, with the existing departments on the St Mary’s
and Royal Brompton campuses, the Faculty of Medicine.
The Kennedy Institute of Rheumatology joined the Faculty of Medicine in 2000 and for over a
decade was unique in Europe for its integration of basic science research and clinical facilities in
23
rheumatology. On 1 August 2011, the Institute moved to Oxford University to build a new centre
for research into rheumatology and inflammatory and autoimmune disease.
In 2007, the Imperial College Healthcare NHS Trust, was formed by merging Hammersmith and St
Mary’s Hospitals’ NHS Trusts with the College, forming the country’s largest NHS Trust. This also
established the UK’s first Academic Health Science Centre (AHSC) bringing together healthcare
services, teaching and research for maximum synergistic benefits.
Imperial College was an independent constituent part of the University of London until July 2007,
when it was granted a new royal charter declaring it an independent university in its own right.
The academic structure of Imperial College is divided into three faculties, the Faculties of
Engineering, Natural Sciences and Medicine. The College’s other major academic unit is the
Business School.
Staff and Students
The academic and research staff of 3,397 includes 72 Fellows of the Royal Society, 77 Fellows of
the Royal Academy of Engineering, 81 Fellows of the Academy of Medical Sciences, one Fellow of
the British Academy, four Crafoord Prize winners and two Fields Medalists. Fourteen Nobel
Laureates have been members of the College either as staff or students.
The College has 14,342 students, of whom 37 percent are postgraduate. Thirty per cent of
students come from outside the European Union. External assessment of the College’s teaching
quality in many different subject areas has been judged to be of high standard. The proportion of
women students is 36 percent of the total.
Research
The quality of the College’s research has been judged consistently to be of the highest
international standard and the proportion of income from research grants and contracts is one of
the highest of any UK university.
The concentration and strength of research in science, engineering and medicine gives the
College a unique and internationally distinctive research presence.
Generous support for the College’s work comes from a wide variety of sources. From industry
there are donations towards certain senior academic posts, advanced courses, bursaries and
scholarships. The single largest contribution to the College from industrial concerns is in the form
of contracts to carry out research. The College also gains considerable support from research
councils and charities to undertake research.
Teaching and Learning
The College’s overall educational aim is to ensure a stretching and exhilarating learning
experience and, while maintaining its traditional emphasis on single honours degree courses, it
also aims to give students the opportunity to broaden their experience through courses relevant to
student and employer needs.
24
In its MSc. course provision, the College seeks to provide a wide range of specialist courses in
areas in which it has particular expertise. Many of those offered by non-medical departments
emphasise the valuable interaction between scientific/technological training and industrial
experience, whilst those offered by the medical departments focus on subjects at the interface
between basic science and medicine and on specialist education for doctors and other health
professionals in training. In addition, the College’s wide range of PhD programmes reflect its aim
of pursuing research at the frontiers of scientific, engineering, management and medical
knowledge and the increasingly interdisciplinary nature of this research.
The Centre for Educational Development raises and consolidates the profile of learning, teaching
and educational development throughout the College. Newly-appointed non-clinical lecturers will
be expected to develop and expand their teaching skills, and there are many learning and teaching
activities for more experienced staff.
On 1 October 2011, the Graduate School of Life Sciences and Medicine merged with the Graduate
School of Engineering and Physical Sciences, to form a single entity. The merged Graduate
School is the focus of postgraduate education and research and maintains, enhances and
monitors quality, disseminates best practice, while initiating and developing new programmes,
particularly those with an interdisciplinary slant. It also has quality assurance responsibilities for
the two non-faculty departments of Humanities and the Business School.
The College’s teaching quality is audited regularly, both internally and externally. Recent external
audit found teaching quality to be of a high standard.
Location
The College now has one of the largest operational estates of any UK University. It includes six
central London campuses, the main South Kensington campus, the Charring Cross campus, the
Chelsea and Westminster campus, the Hammersmith campus, the Royal Brompton campus and
St Mary’s campus.
Silwood Park, a postgraduate campus at Ascot in Berkshire, houses the Ecology and Evolution
Section of the Biology Division, in the Department of Life Sciences. The successful Master’s
courses in Crop Protection, Forest Protection and Ecology, Evolution and Conservation are run at
Silwood together with the newly created Master’s course in Conservation Science, and there is a
thriving postgraduate community. The campus houses excellent research facilities and a wide
range of natural environments. The NERC funded Centre for Population Biology is also based at
Silwood, together with a Business Centre.
THE FACULTY OF MEDICINE
The Faculty of Medicine is one of Europe’s largest medical institutions – in terms of its staff and
student population and its research income. It was established in 1997, bringing together all the
major West London medical schools into one world-class institution. It maintains close links with a
number of NHS Trusts with whom it collaborates in teaching and research activities.
Although on several sites, its academic Schools, Institutes and Departments function as one
Faculty, fully integrated within the College. The current Dean, Professor Dermot Kelleher, took up
his appointment in October 2012.
25
There are five academic Schools, Institutes and Departments:
Schools, Institutes and Departments





Head of School/Institute/Department
Department of Medicine
Department of Surgery and Cancer
Institute for Clinical Sciences
National Heart and Lung Institute
School of Public Health
Professor Gavin Screaton
Professor Jeremy Nicholson
Professor Amanda Fisher
Professor Kim Fox
Professor Elio Riboli
Faculty of Medicine Executive Team
Dean of the Faculty of Medicine
Vice-Dean for Education and Institutional Affairs
Vice-Dean for Research
Vice-Dean for Health Policy and Engagement
Vice-Dean for Academic Development
Professor Dermot Kelleher
Professor Jenny Higham
Professor Jonathan Weber
Professor Lord Ara Darzi
Professor Gavin Screaton
26
APPENDIX 2
SALARY AND CONDITIONS OF SERVICE
A full set of terms and conditions will be given to the successful candidate, together with the
College’s most important policies which affect staff. The principal terms and conditions are as
follows:
For staff who will hold an honorary consultant contract, appointment will be made at an appropriate
point on the new Consultant Clinical Academic pay scale according to seniority plus the London
Allowance. Calculation of basic salary and pay thresholds are based on the level of seniority of the
applicant's service.
All appointments at Clinical Senior Lecturer level have a Training and Development Review period,
which lasts 5 years.
Annual cost of living increases will be determined in line with the recommendations of the
Universities and Colleges Employers’ Association’s Clinical Academic Staff Salaries Committee
(CASSC).
As this post is exempt from the Rehabilitation of Offenders Act 1974, a satisfactory enhanced
Disclosure and Barring Service check will be required for the successful candidate. Further
information
about
the
DBS
disclosure
process
can
be
found
at
http://www.homeoffice.gov.uk/agencies-public-bodies/dbs/ or by telephoning 0870 90 90 811. You
may also wish to view the College’s policy statements on the Recruitment and Employment of ExOffenders and the Secure Storage, Use, Retention & Disposal of Disclosures and Disclosure
Information.
Clinical academic members of staff are entitled to paid annual leave and are encouraged to take it.
Additional leave may also be taken for conferences, networking and to pursue research and
collaborative interests. Academic members of staff normally take leave during College vacations.
All leave is taken by arrangement with the Head of Department in the light of academic and
departmental requirements.
Personal annual leave entitlement is 30 days (pro rata for part-time staff).
Staff are also entitled to 10 days public holidays per annum (including two statutory days).
College closure days are allocated in addition to public holidays at Christmas and Easter. There is
no obligation for staff to take days during college closure dates but if you do, this must be taken as
part of your annual leave entitlement.
Salaries are payable on the 24th day of each month (the exception being December) by transfer to
a bank or building society account. Deductions in respect of income tax and National Insurance
contributions will be made from salaries at the statutory rates.
The occupational pension scheme is the Universities Superannuation Scheme (USS). Staff who
are already members of the Federated Superannuation System for Universities (FSSU) or the
National Health Service Superannuation Scheme (NHSPS) may, if they are still eligible, retain their
membership in these schemes.
27
Unless stated otherwise in the offer of employment, or agreed by the head of department, the
appointment may be terminated by either side by giving a minimum of three months’ notice in
writing. The last day of service should fall on one of the following dates: 31 December; 31 March;
30 June or 30 September or at the end of a term by agreement with the Head of Department.
28